Cite
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
MLA
Raju, Sharat C., et al. “Combined TP53 Mutation/3p Loss Correlates with Decreased Radiosensitivity and Increased Matrix-Metalloproteinase Activity in Head and Neck Carcinoma.” Oral Oncology, vol. 51, no. 5, May 2015, pp. 470–75. EBSCOhost, https://doi.org/10.1016/j.oraloncology.2015.01.014.
APA
Raju, S. C., Hauff, S. J., Lemieux, A. J., Orosco, R. K., Gross, A. M., Nguyen, L. T., Savariar, E., Moss, W., Whitney, M., Cohen, E. E., Lippman, S. M., Tsien, R. Y., Ideker, T., Advani, S. J., & Nguyen, Q. T. (2015). Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncology, 51(5), 470–475. https://doi.org/10.1016/j.oraloncology.2015.01.014
Chicago
Raju, Sharat C., Samantha J. Hauff, Aaron J. Lemieux, Ryan K. Orosco, Andrew M. Gross, Linda T. Nguyen, Elamprakash Savariar, et al. 2015. “Combined TP53 Mutation/3p Loss Correlates with Decreased Radiosensitivity and Increased Matrix-Metalloproteinase Activity in Head and Neck Carcinoma.” Oral Oncology 51 (5): 470–75. doi:10.1016/j.oraloncology.2015.01.014.